The definitive version of Divinity: Original Sin 2, the sequel to Original Sin first released back in 2017, is now available for the PS5, Nintendo Switch 2 and Xbox X|S. The role-playing game was ...

Pam's Colecovision was her babysitter, from the age of 4 or 5, but the family only had one game. Over and over, hour after hour, she'd climb and jump through the three levels of Donkey Kong. But the ...

Did you see that Divinity reveal at The Game Awards and think, hey, I really should get around to playing Divinity: Original Sin 2? Great news, Larian just made it a much nicer experience on modern ...

Larian Studios has announced that Divinity: Original Sin II — Definitive Edition is now available for PS5, Nintendo Switch 2, and Xbox Series X/S, with those of you who own the game already on PS4 ...

Tech care leader Asurion and national nonprofit Cell Phones for Soldiers have launched a new partnership to support veterans by donating 775 smartphones to veterans in Middle Tennessee and beyond -- ...

Larian Studios recently announced its hit PS4 RPG, Divinity: Original Sin 2, now has a PS5 version available to purchase today on the PlayStation Store. Players who already own the game can upgrade to ...

TheWell Bioscience manufactures VitroGel®, an innovative xeno-free biofunctional hydrogel system used as a next-generation alternative to animal-based ECM such as Matrigel coupled with the xeno-free ...

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...

Researchers discovered that a long-misunderstood protein plays a key role in helping chromosomes latch onto the right “tracks” during cell division. Instead of acting like a motor, it works more like ...

The U.S. Food and Drug Administration has approved Omisirge (omidubicel-onlv) as the first hematopoietic stem cell transplant therapy to treat patients with severe aplastic anemia (SAA). Omisirge is ...

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest forms of blood cancer, T-cell acute lymphoblastic leukaemia. By precisely ...